Christina Ann Bandera MD

Chief of Obstetrics and Gynecology, Rhode Island and The Miriam Hospitals

Paul Bertone, PhD

Core Director (Single Cell Technologies); TRDG Member, Bioinfomatics Single cell profiling

Alexander Brodsky
Alexander Brodsky, PhD

Cancer metabolism, Tumor stroma, Immune biomarkers

Sonja Chen
Sonja Chen, MD

Pathology

Mary-Kate Cushing

Genetic Counseling

Michelle Dawson
Michelle Dawson, PhD

Quantitative biophysical analysis, Cell-matrix interactions, Tumor heterogeneity

Paul DiSilvestro, MD

Co-Chair, NRG, Breast, ovarian cancer

Don Dizon
Don Dizon, MD

TRDG Leader (GYN Cancers), Director, Women’s Cancers, Lifespan, GYN cancer therapeutics

Wafik El-Deiry
Wafik El-Deiry, MD, PhD, FACP

Director, Joint Program in Cancer Biology; TRDG Leader and Facilitator, Drug Discovery, Signaling, drug resistance, TRAIL, p53, p21, ONC201

Christine Emmick
Christine Emmick, MD

Surgical Oncology

Tarra Evans
Tarra Evans, MD

Gynecological Oncology

Maria Garcia-Moliner, MD

Mitochondria changes in cancer, LAM

Jesse Hart
Jesse Hart, DO

Director of Immunohistochemistry, Lifespan Laboratories

Nicole James

Postdoc

Ana Lourenco
Ana Lourenco, MD

Diagnostic Imaging

Lauren Massingham
Lauren Massingham, MD

Clinical Geneticist

Matt Oliver, MD

Gynecological Oncology

Chanika Phornphutkul
Chanika Phornphutkul, MD

Chief of the Division of Human Genetics and Director of Genetics and Metabolism Clinic at Rhode Island/Hasbro Children's Hospital

M. Yakub Puthawala
M. Yakub Puthawala, MD

Chief of brachytherapy, Gynecologic Cancers, Head, Neck And Thyroid Cancer, Skin Cancer

Jennifer Ribeiro
Jennifer Ribeiro, PhD

Gyn Research

Katina Robison
Katina Robison, MD

Gynecological Oncology

Howard Safran, MD

Group Leader (Cancer Therapeutics); TRDG Leader and Facilitator, Medical Director, BrUOG, Chief, Hematology/Oncology, Brown and Lifespan, GI and brain cancer therapeutics, Experimental therapeutics

Neil Sarkar
Neil Sarkar, PhD

Group Leader (Population Science); Biomedical Informatics, Health Services and Policy

Attila A Seyhan, PhD

Director of Translational Oncology Operations, Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute; Core Director of Translational Oncology; Adjunct Associate Professor, Tumor metabolism and RNA processing

William Sikov
William Sikov, MD

TRDG Leader (Breast Cancer), Breast cancer, Clinical trials

Kamaljeet Singh, MBBS

Assistant Professor of Pathology and Laboratory Medicine

Robert Sobol, PhD
Robert Sobol, PhD

Professor of Pathology and Laboratory Medicine, Cancer DNA damage and repair, DNA replication, Environmental toxicology, mouse models, NAD (Coenzyme) , PARP

C. James Sung, MD

Chief of Pathology and Laboratory Medicine at Women & Infants Hospital of RI, executive chief of pathology and laboratory medicine at Care New England, and Vice Chair of Pathology and Laboratory Medicine at The Warren Alpert Medical School of Brown U.

Xiaobing Tian, PhD

Core Director (Organic Synthesis); Research Assistant Professor, Integrated stress response, Cell signaling, Myc, Puma, p53

Alper Uzun
Alper Uzun, PhD

Associate Professor of Pathology and Laboratory Medicine (Research), Associate Professor of Pediatrics (Research), Director, Legorreta Cancer Center Bioinformatics at Brown University

Dilber Ece Uzun
Dilber Ece Uzun, PhD

Clinical bioinformatics, Drug absorption

Yihong Wang, MD, PhD

Breast cancer, miRNA, Wnt signaling

Robert Ward
Robert Ward, MD

Diagnostic Imaging

Esther Yu
Esther Yu, MD

Radiation Oncology

Yiqun Zhang, PhD

Translational Therapeutics

Shengliang Zhang, MD, PhD

Core Director (Drug Discovery); Research Assistant Professor, ROS, ERK2, MDM2, p53

Shuai Zhao, PhD candidate

Translational Therapeutics

Lanlan Zhou, MD, PhD

Core Director (Organoids); Research Assistant Professor), Translational therapeutics, Biomarkers